venerdì, Marzo 29, 2024

Prodotti per la casa e danno alle cellule della mielina: il pericolo invisibile che danneggia maggiormente i bambini

L'esposizione umana alle sostanze chimiche ambientali, soprattutto durante le...

Trigonellina: l’alcaloide che agisce come tale ma anche come precursore di coenzimi enzimatici anti-aging

La sarcopenia è il declino correlato all’età del muscolo...

Liver cancer: “malignant pathways” are already there in cirrhosis

Liver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cure — but now a study offers hope of early detection, and targets for new treatments. Published in Frontiers in Cell and Developmental Biology, the results show a dramatic increase in expression of sugar-burning ‘glycolytic’ enzymes in precancerous cirrhotic livers. This increase is associated with a significantly higher risk of developing hepatocellular carcinoma (HCC) — the main type of liver cancer — and could lead to a biomarker which identifies those at risk of malignancy. It is known that almost 90% of all hepatocellular carcinoma cases start with liver cirrhosis. In cirrhosis, chronic damage caused by hepatitis viruses B or C, alcohol, or obesity leads to scarring and formation of regenerative nodules in the liver. High cell turnover in these nodules, with accumulation of genetic damage, can eventually produce cancerous cells. So by pinpointing when cirrhosis progresses to cancer, clinicians could improve early detection and treatment perhaps with new treatments which reverse the transition.

For nearly a century, scientists have recognized that cancer cells shift the way they generate energy. Normally the body obtains energy from macronutrients — sugars, fats, proteins and their intermediaries — primarily using oxygen. But our cells can also extract energy from sugars without using oxygen. This anaerobic process, called glycolysis, produces lactic acid that ‘burns’ our muscles during intense exercise — and is also used by cancers to fuel their rampant growth. Like virtually all cancers, highly-proliferating HCC cells seem to readjust their energy metabolism towards glycolysis, irrespective of oxygen availability. The cause of this shift in glucose metabolism — known as the Warburg effect — remains unknown, but inflammation is thought to play a role. Since cirrhosis is an inflammatory process, the team decided to look at whether the metabolic shift to glycolysis is present already in cirrhotic cells — and whether this predicts progression to hepatocellular carcinoma. They analyzed normal, cirrhotic and cancerous (HCC) liver samples from patients followed up over 10 years following a liver biopsy. To have a complete overview of energy metabolism changes in HCC and premalignant stages of disease, they measured the expression of genes encoding enzymes involved in glycolysis and other metabolic pathways.

They found that glycolysis-related genes, like hexokinase 2 (HK2), aldolase A (ALDOA) and pyruvate kinase M2 (PKM2) are highly expressed not only in HCC, but also in cirrhosis as compared to normal liver samples. In other words: the shift to glycolysis occurs in the precancerous stage.  Even more striking, the level of expression of glycolysis-related genes showed positive correlation with progression of cirrhosis to HCC — and with poor outcome in those with HCC already at the time of biopsy. Besides, it is known that nuclear PKM2 acts as a co-activator of β-catenin to induce c-MYC oncogene and glycolytic gene expression, therefore stimulating tumor growth through indirect mechanisms. Moreover, cancer cells facilitate the uptake of glucose and the incorporation of glycolytic metabolites into amino acids, nucleic acids, and lipids. While adapting to these new metabolic needs, the Warburg effect produces increased levels of antioxidant proteins to detoxify reactive oxygen species (ROS). These are responsible for the activation of the stress kinase JNK1 seen in cirrhotic livers and in highly proliferating hepatocarcinomas. In their previous work, the team has noted an existing PKM2-JNK1 axis that could be responsible for the growth advantage. Reduced PKM2 activity allows the accumulation of glucose-6-phosphate, shifting the glucose flux through the pentose phosphate pathway (PPP) to generate NADPH, and consequently reduced glutathione (GSH), the main cellula antioxidant.

Study senior authors Dr. Salvatore Papa of the University of Leeds and Dr. Concetta Bubici of Brunel University London, commented: “This suggests expression of glycolytic enzymes could be used as a new biomarker to predict the risk of later development of HCC in patients with cirrhosis. Further studies are needed to establish whether these changes in gene expression are borne out as changes in glycolytic activity. The shift to a glycolytic expression profile in cirrhotic cells could even be a target for new HCC therapies. For example, clinical trials are currently underway to explore the effect of statins — which are used to help prevent cardiovascular disease — on HCC development in cirrhotic patients or HCC recurrence following surgical removal. It is very likely that by blocking cholesterol synthesis, statins would also suppress glycolysis as these chemical pathways overlap. If these trials show that statins reduce HCC risk, further studies would be necessary to establish whether inhibition of glycolysis in cirrhotic cells is responsible”.

  • Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.

Scientific references

Bubici Cet al., Papa S. Front Cell Dev Biol. 2018 Nov.

Papa S, Bubici C. J Hepatol. 2018 Sep; 69(3):572-574. 

Papa S, Bubici C. Mol Cell Oncol. 2016; 3(2):e1103398. 

Iansante V et al., Papa S. Nat Commun. 2015; 6:7882.

Latest

Prodotti per la casa e danno alle cellule della mielina: il pericolo invisibile che danneggia maggiormente i bambini

L'esposizione umana alle sostanze chimiche ambientali, soprattutto durante le...

Synucleinopathy diagnosis is “under the skin”: biopsy as the next generation tool for early detection

Synucleinopathies are neurodegenerative illnesses that cause phosphorylated alpha-synuclein protein...

Newsletter

Don't miss

Prodotti per la casa e danno alle cellule della mielina: il pericolo invisibile che danneggia maggiormente i bambini

L'esposizione umana alle sostanze chimiche ambientali, soprattutto durante le...

Synucleinopathy diagnosis is “under the skin”: biopsy as the next generation tool for early detection

Synucleinopathies are neurodegenerative illnesses that cause phosphorylated alpha-synuclein protein...

Il ruolo delle vitamine liposolubili nelle sindromi neuropsichiatriche

Introduzione La salute mentale è una componente integrale ed essenziale...
Dott. Gianfrancesco Cormaci
Dott. Gianfrancesco Cormaci
Laurea in Medicina e Chirurgia nel 1998, specialista in Biochimica Clinica dal 2002, ha conseguito dottorato in Neurobiologia nel 2006. Ex-ricercatore, ha trascorso 5 anni negli USA alle dipendenze dell' NIH/NIDA e poi della Johns Hopkins University. Guardia medica presso la casa di Cura Sant'Agata a Catania. In libera professione, si occupa di Medicina Preventiva personalizzata e intolleranze alimentari. Detentore di un brevetto per la fabbricazione di sfarinati gluten-free a partire da regolare farina di grano. Responsabile della sezione R&D della CoFood s.r.l. per la ricerca e sviluppo di nuovi prodotti alimentari, inclusi quelli a fini medici speciali.

“La bellezza è sotto la pelle”: forse vale per colore e sensibilità, ma non sembra così per la psoriasi

Si stima che circa 125 milioni di persone in tutto il mondo soffrano di malattia psoriasica, senza differenze fra uomini e donne. Ma al...

Gli sforzi contro Crohn & Co.: ed è sempre più chiaro che il problema è nelle comunità intestinali

La malattia infiammatoria intestinale (IBD) è una condizione cronica e recidivante che ha un impatto significativo sulla qualità della vita e che necessita di...

Cosa ne pensa la scienza dei legami fra consumo di pasta e sovrappeso/obesità? Una recensione

La pasta è stata ed è ancora un carboidrato fondamentale in numerose culture; tuttavia, è stato collegato all'obesità a causa del suo stato di...